激酶
磷酸肌醇3激酶
PI3K/AKT/mTOR通路
突变体
生物
班级(哲学)
酶
细胞生物学
计算生物学
生物化学
化学
信号转导
基因
计算机科学
人工智能
作者
L. Mario Amzel,Chuan‐Hsiang Huang,Diana Mandelker,Christoph Lengauer,Sandra B. Gabelli,Bert Vogelstein
出处
期刊:Nature Reviews Cancer
[Springer Nature]
日期:2008-07-17
卷期号:8 (9): 665-669
被引量:93
摘要
The recent determination of the structure of the class I phosphoinositide 3-kinase PI3Kα has identified important structural differences between the class 1 PI3Ks. How can this information be used to improve cancer therapy? Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that regulate cell growth. One of these kinases, PI3Kα, is frequently mutated in diverse tumour types. The recently determined structure of PI3Kα reveals features that distinguish this enzyme from related lipid kinases. In addition, wild-type PI3Kγ differs from PI3Kα by a substitution identical to a PI3Kα oncogenic mutant (His1047Arg) that might explain the differences in the enzymatic activities of the normal and mutant PI3Kα. Comparison of the PI3K structures also identified structural features that could potentially be exploited for the design of isoform-specific inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI